We research, develop and commercialize new healthcare technologies that help save lives around the world.
What We Do
Covalon uses science and technology to help solve major medical challenges associated with prevention, detection and management of areas such as infection, tissue repair, medical device biocompatibility, and condition management.
Together, our technology platforms, wound care products, and consulting services deliver a suite of cost-effective solutions to help our customers achieve product differentiation through improved patient outcomes.
The Advanced Wound Care Market
Estimated at $5 billion (U.S), is projected to grow approximately 8% per year driven by increases in pressure and diabetic ulcers related to the growth of an aging population and the increased prevalence of diabetes. Covalon’s proprietary pro-active collagen technology serves this growing demand, and is customizable to create unique tissue repair products for the orthopaedic, neurological, dental, and ocular spaces.
The Infection Control Market
Which includes Healthcare Acquired Infections (HAI), is not only a growing healthcare issue, but a significant financial one as well. In the United States alone, the additional costs of HAIs are estimated to cost the system an additional $45 billion a year, and is therefore being aggressively targeted by all jurisdictions. Covalon’s proprietary infection control technology is a customized platform for coatings, vascular access, and wound care products.
The Medical Device Coatings Market
Estimated by Global Industry Analytics to exceed $7.5 billion by the year 2015. Covalon’s proprietary technology delivers therapeutics, such as silver ions from medical device surfaces for extended periods of time thereby creating an antimicrobial or therapeutic surface coating. The coatings can be applied to silicone and latex catheters, peritoneal dialysis catheters, hemodialysis catheters, wound drains, central venous lines, orthopaedic metals and many other medical devices. Our proprietary coating can be formulated to provide controlled delivery of various therapeutics for a wide range of devices and is supported by an FDA device master file.
Covalon was founded by a group of entrepreneurial PhD’s from the University of Toronto who recognized an opportunity to serve the global community through the development of patented medical technology in the areas of infection control, advanced wound care and medical coatings.
Covalon became a publically traded company in 2004 and successfully built partnerships with both small and large companies using a strategic business foundation based on advanced scientific and engineering know-how. Starting in 2010, Covalon added a management team with significant success in growing medical companies to help propel Covalon forward into a mature and well respected medical industry partner.
Covalon is an ISO 13485:2003 registered company made up of a team of cross disciplinary scientists and engineers who utilize an in house laboratory to carry out feasibility studies, product formulation, prototype testing, validation, regulatory clearances and manufacturing for any size of project. Where appropriate, we design a product to meet the requirements of the most beneficial billing codes.
Covalon’s award winning team works closely with multiple stakeholders within each company to develop customized products that offer strategic marketing advantages, improved clinical outcomes, and favourable pricing models.
Major medical device manufacturers and distributors have contracted with us to develop and commercialize proprietary technologies in the areas of advanced wound care, urology, cardiology, vascular access, orthopaedics and surgery. Our partners include the top medical device companies, leaders in orthopaedic implants, large public and private medical device distributors, world leaders in wound care, niche specialty medical device companies and major contract manufacturers of medical devices.
We deal with highly sensitive and competitive information when working with partners and are serious about confidentiality. Many of our relationships are confidential & prevent us from disclosing details about our customer base, projects & accomplishments.
Over eighty-five percent of our staff hold advanced academic degrees, with core competences in chemistry, biology, microbiology and physics, and are recognized in the medical industry as leading experts in:
- Customized medical device coatings
- Antimicrobial and infection control technologies
- Advanced wound care dressings
- Advanced drug delivery technologies
In 2011, Covalon expanded its sales, business development and marketing initiatives with the addition of experienced medical industry sales, business development and marketing staff. Their focus is on developing new business opportunities for the Company's core wound care products and medical coating services, however, the team is also working on the introduction of promising new technologies and formulations for Covalon's existing channels and direct to consumers.